ArticleCancers2022

The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.

Maximilian Haist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.